搜尋





搜尋





市場行情
/
股票
/
vyne
/

Vyne Therapeutics Inc

VYNE

添加自選

28.560USD

0.0000.00%

收盤 07-27 16:00（美東）報價延遲15分鐘

18.71M總市值

虧損本益比TTM

Vyne Therapeutics Inc

28.560

0.0000.00%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

VYNE 利潤表

您可以在這裡找到Vyne Therapeutics Inc的年度或季度收入報告，以深入了解Vyne Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

營業總收入

-57.43%86.00K

54.76%130.00K

39.67%169.00K

-65.15%69.00K

106.12%202.00K

10.53%84.00K

6.14%121.00K

46.67%198.00K

-1.01%98.00K

1166.67%76.00K

-31.74%114.00K

7.14%135.00K

-44.38%99.00K

-99.74%6.00K

-95.91%167.00K

-57.29%126.00K

-22.61%178.00K

-46.52%2.29M

24.99%4.09M

-97.48%295.00K

-86.86%230.00K

--4.29M

--3.27M

--11.69M

468.18%1.75M

--0.00

-100.00%0.00

-38.03%308.00K

-100.00%0.00

2159.02%10.14M

10.69%497.00K

516.67%2.77M

305.80%909.00K

--449.00K

--450.00K

--224.00K

營業收入

-57.43%86.00K

54.76%130.00K

39.67%169.00K

-65.15%69.00K

106.12%202.00K

10.53%84.00K

6.14%121.00K

46.67%198.00K

-1.01%98.00K

1166.67%76.00K

-31.74%114.00K

7.14%135.00K

-44.38%99.00K

-99.74%6.00K

-95.91%167.00K

-57.29%126.00K

-22.61%178.00K

-46.52%2.29M

24.99%4.09M

-97.48%295.00K

-86.86%230.00K

--4.29M

--3.27M

--11.69M

468.18%1.75M

--0.00

-100.00%0.00

-38.03%308.00K

-100.00%0.00

2159.02%10.14M

10.69%497.00K

516.67%2.77M

305.80%909.00K

--449.00K

--450.00K

--224.00K

主營業務成本

----

69.10%903.00K

182.75%1.05M

----

--534.00K

--371.00K

--216.00K

--271.00K

----

--0.00

----

營業費用

-58.48%3.90M

-58.39%5.35M

-39.74%7.96M

-28.16%7.61M

25.69%9.40M

86.07%12.85M

108.13%13.21M

1.35%10.59M

25.18%7.48M

-13.54%6.91M

-33.18%6.35M

24.25%10.45M

-32.64%5.97M

-44.27%7.99M

-56.55%9.50M

-14.48%8.41M

-11.19%8.87M

-45.44%14.34M

-18.30%21.86M

-94.50%9.84M

-76.02%9.99M

19.81%26.27M

15.35%26.76M

823.94%178.87M

157.16%41.64M

18.93%21.93M

69.31%23.20M

0.22%19.36M

18.04%16.19M

50.51%18.44M

48.21%13.70M

189.42%19.32M

128.46%13.72M

127.94%12.25M

150.00%9.24M

--6.67M

--6.00M

--5.38M

--3.70M

研發費用

-86.66%817.00K

-69.26%2.98M

-48.71%5.26M

-33.19%4.88M

65.16%6.12M

220.34%9.68M

208.86%10.25M

1.01%7.31M

35.63%3.71M

-29.35%3.02M

-40.17%3.32M

76.07%7.23M

-38.59%2.73M

-18.26%4.28M

-20.56%5.55M

-18.62%4.11M

4.63%4.45M

-33.21%5.24M

5.41%6.98M

-61.52%5.05M

-73.33%4.25M

-33.34%7.84M

-46.81%6.62M

4.48%13.12M

47.06%15.95M

-22.01%11.76M

16.73%12.45M

-22.62%12.56M

-1.56%10.85M

42.95%15.08M

33.19%10.67M

197.18%16.23M

120.75%11.02M

158.67%10.55M

180.82%8.01M

--5.46M

--4.99M

--4.08M

--2.85M

折舊攤銷及損耗

0.00%6.00K

25.00%5.00K

--6.00K

--4.00K

----

--0.00

-100.00%0.00

----

510.71%171.00K

-57.14%12.00K

62.96%44.00K

-70.11%26.00K

-58.21%28.00K

-70.21%28.00K

-70.97%27.00K

569.23%87.00K

-27.96%67.00K

8.05%94.00K

22.37%93.00K

8.33%13.00K

2225.00%93.00K

8600.00%87.00K

1420.00%76.00K

300.00%12.00K

300.00%4.00K

-50.00%1.00K

150.00%5.00K

50.00%3.00K

0.00%1.00K

--2.00K

--1.00K

其他營業費用

----

--0.00

----

--0.00

--139.07M

----

--0.00

----

營業利潤

58.51%-3.82M

59.13%-5.22M

40.48%-7.79M

27.45%-7.54M

-24.62%-9.20M

-86.91%-12.77M

-109.99%-13.09M

-0.76%-10.40M

-25.62%-7.38M

14.43%-6.83M

33.20%-6.23M

-24.51%-10.32M

32.40%-5.88M

33.71%-7.98M

47.50%-9.33M

13.15%-8.29M

10.93%-8.69M

45.23%-12.04M

24.33%-17.78M

94.29%-9.54M

75.54%-9.76M

-0.27%-21.99M

-1.26%-23.49M

-763.56%-167.18M

-151.13%-39.89M

-18.93%-21.93M

-69.31%-23.20M

-111.04%-19.36M

-20.15%-15.88M

-94.58%-18.44M

-64.37%-13.70M

-47.36%-9.17M

-137.98%-13.22M

-92.43%-9.48M

-139.95%-8.34M

---6.22M

---5.55M

---4.92M

---3.47M

淨非營業利息收入（費用）

利息收入

----

-98.05%3.00K

----

-82.12%32.00K

----

--154.00K

--162.00K

--179.00K

----

利息費用

----

--0.00

----

--0.00

-100.00%0.00

218.13%3.47M

0.09%1.07M

-0.47%1.06M

--1.16M

231.91%1.09M

--1.07M

----

--329.00K

--0.00

----

出售證券收益

----

-162.44%-133.00K

-91.18%18.00K

-23.38%249.00K

----

--213.00K

--204.00K

--325.00K

----

特殊收入（費用）

----

--533.00K

--442.00K

----

--0.00

----

其他非經營性收入（費用）

-61.11%231.00K

-65.39%263.00K

-60.81%366.00K

79.32%1.79M

-47.85%594.00K

11.76%760.00K

473.01%934.00K

257.50%1.00M

333.08%1.14M

188.14%680.00K

108.97%163.00K

438.46%280.00K

8866.67%263.00K

807.69%236.00K

322.86%78.00K

175.36%52.00K

94.74%-3.00K

183.87%26.00K

---35.00K

---69.00K

---57.00K

---31.00K

----

稅前利潤

58.33%-3.58M

58.73%-4.96M

38.92%-7.43M

38.83%-5.75M

-37.85%-8.60M

-95.22%-12.01M

-100.25%-12.16M

6.41%-9.39M

-11.21%-6.24M

20.60%-6.15M

34.40%-6.07M

-21.89%-10.04M

35.45%-5.61M

35.53%-7.75M

56.52%-9.26M

22.93%-8.23M

20.06%-8.69M

48.16%-12.02M

13.87%-21.29M

93.63%-10.69M

72.97%-10.88M

-7.83%-23.18M

-6.70%-24.71M

-782.95%-167.70M

-161.59%-40.23M

-22.20%-21.50M

-80.28%-23.16M

-127.54%-18.99M

-21.51%-15.38M

-89.66%-17.59M

-57.19%-12.85M

-35.66%-8.35M

-131.22%-12.66M

-91.77%-9.28M

-140.52%-8.17M

---6.15M

---5.47M

---4.84M

---3.40M

所得稅

--0.00

0.00%4.00K

--0.00

--4.00K

----

--0.00

-100.00%0.00

--0.00

102.90%13.00K

--0.00

---448.00K

-100.00%0.00

100.00%0.00

--0.00

--1.00K

---259.00K

100.00%0.00

----

--0.00

---176.00K

----

---7.00M

----

除稅後利潤

58.33%-3.58M

58.71%-4.96M

38.92%-7.43M

38.83%-5.75M

-37.85%-8.60M

-95.29%-12.01M

-100.25%-12.16M

6.41%-9.39M

-11.21%-6.24M

20.73%-6.15M

34.40%-6.07M

-21.89%-10.04M

35.45%-5.61M

32.92%-7.76M

56.52%-9.26M

22.93%-8.23M

20.06%-8.69M

50.09%-11.57M

13.87%-21.29M

93.62%-10.69M

72.97%-10.88M

-7.83%-23.18M

-6.71%-24.71M

-781.59%-167.44M

-164.62%-40.23M

-22.20%-21.50M

-80.28%-23.16M

-127.54%-18.99M

-20.12%-15.20M

-672.98%-17.59M

-57.19%-12.85M

-35.66%-8.35M

-131.22%-12.66M

52.95%-2.28M

-140.52%-8.17M

---6.15M

---5.47M

---4.84M

---3.40M

持續經營利潤

58.33%-3.58M

58.71%-4.96M

38.92%-7.43M

38.83%-5.75M

-37.85%-8.60M

-95.29%-12.01M

-100.25%-12.16M

6.41%-9.39M

-11.21%-6.24M

20.73%-6.15M

34.40%-6.07M

-21.89%-10.04M

35.45%-5.61M

32.92%-7.76M

56.52%-9.26M

22.93%-8.23M

20.06%-8.69M

50.09%-11.57M

13.87%-21.29M

93.62%-10.69M

72.97%-10.88M

-7.83%-23.18M

-6.71%-24.71M

-781.59%-167.44M

-164.62%-40.23M

-22.20%-21.50M

-80.28%-23.16M

-127.54%-18.99M

-20.12%-15.20M

-672.98%-17.59M

-57.19%-12.85M

-35.66%-8.35M

-131.22%-12.66M

52.95%-2.28M

-140.52%-8.17M

---6.15M

---5.47M

---4.84M

---3.40M

停止經營利潤

----

--146.00K

27.27%-8.00K

0.00%-8.00K

----

100.00%0.00

45.00%-11.00K

20.00%-8.00K

98.35%-36.00K

-151.47%-513.00K

91.70%-20.00K

-100.07%-10.00K

---2.18M

---204.00K

97.39%-241.00K

238.14%13.36M

----

---9.24M

---9.67M

----

反常淨利潤

----

---7.00M

----

其他淨損益

----

---8.00K

----

歸屬少數股東的淨利潤

----

--0.00

----

歸属于母公司的淨利潤

58.37%-3.58M

59.77%-4.84M

40.12%-7.28M

38.82%-5.75M

-37.80%-8.61M

-94.28%-12.02M

-84.64%-12.16M

6.48%-9.41M

-11.15%-6.25M

37.78%-6.19M

30.39%-6.58M

-18.66%-10.06M

-220.39%-5.62M

14.04%-9.95M

55.56%-9.46M

57.46%-8.48M

122.73%4.67M

50.09%-11.57M

13.87%-21.29M

88.10%-19.92M

48.92%-20.55M

-7.83%-23.18M

-6.71%-24.71M

-781.59%-167.44M

-164.62%-40.23M

-22.20%-21.50M

-80.28%-23.16M

-127.54%-18.99M

-20.12%-15.20M

-89.66%-17.59M

-57.19%-12.85M

-35.66%-8.35M

-131.22%-12.66M

-91.77%-9.28M

-140.52%-8.17M

---6.15M

---5.47M

---4.84M

---3.40M

歸屬普通股東的淨利潤

58.37%-3.58M

59.77%-4.84M

40.12%-7.28M

38.82%-5.75M

-37.80%-8.61M

-94.28%-12.02M

-84.64%-12.16M

6.48%-9.41M

-11.15%-6.25M

37.78%-6.19M

30.39%-6.58M

-18.66%-10.06M

-220.39%-5.62M

14.04%-9.95M

55.56%-9.46M

57.46%-8.48M

122.73%4.67M

50.09%-11.57M

13.87%-21.29M

88.10%-19.92M

48.92%-20.55M

-7.83%-23.18M

-6.71%-24.71M

-781.59%-167.44M

-164.62%-40.23M

-22.20%-21.50M

-80.28%-23.16M

-127.54%-18.99M

-20.12%-15.20M

-89.66%-17.59M

-57.19%-12.85M

-35.66%-8.35M

-131.22%-12.66M

-91.77%-9.28M

-140.52%-8.17M

---6.15M

---5.47M

---4.84M

---3.40M

基本每股收益

58.46%-0.08

60.01%-0.11

40.42%-0.17

39.06%-0.13

-37.50%-0.20

-42.72%-0.28

85.77%-0.29

92.81%-0.22

91.50%-0.15

93.59%-0.20

31.74%-2.01

-16.65%-3.07

-213.80%-1.73

20.70%-3.08

60.09%-2.94

62.25%-2.63

120.05%1.52

60.60%-3.89

30.58%-7.36

91.98%-6.98

88.89%-7.57

84.60%-9.87

35.87%-10.61

-523.09%-86.95

-100.50%-68.14

-17.30%-64.09

58.91%-16.54

46.89%-13.95

34.42%-33.99

-113.76%-54.64

-50.01%-40.26

-30.06%-26.28

-188.35%-51.83

-60.94%-25.56

-140.53%-26.84

---20.20

---17.97

---15.88

---11.16

稀釋每股收益

58.46%-0.08

60.01%-0.11

40.42%-0.17

39.06%-0.13

-37.50%-0.20

-42.72%-0.28

85.77%-0.29

92.81%-0.22

91.50%-0.15

93.59%-0.20

31.74%-2.01

-16.65%-3.07

-213.80%-1.73

20.70%-3.08

60.09%-2.94

62.25%-2.63

120.05%1.52

60.60%-3.89

30.58%-7.36

91.98%-6.98

88.89%-7.57

84.60%-9.87

35.87%-10.61

-523.09%-86.95

-100.50%-68.14

-17.30%-64.09

58.91%-16.54

46.89%-13.95

34.42%-33.99

-113.76%-54.64

-50.01%-40.26

-30.06%-26.28

-188.35%-51.83

-60.94%-25.56

-140.53%-26.84

---20.20

---17.97

---15.88

---11.16

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Vyne Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 VYNE 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Vyne Therapeutics Inc 財年末的營收是多少？



Vyne Therapeutics Inc 2025 財年營收為 570.00K，高於上一財年的 501.00K。

Vyne Therapeutics Inc 最近一個季度的營收是多少？



Vyne Therapeutics Inc 最近一個季度的營收為 86.00K，同比增長 -57.43%。

Vyne Therapeutics Inc 全年的淨利潤是多少？



Vyne Therapeutics Inc 2025 財年淨利潤為 -26.48M。

Vyne Therapeutics Inc 上一季度的淨利潤是多少？



Vyne Therapeutics Inc 最近一個季度的淨利潤為 -3.58M。

Vyne Therapeutics Inc 年度營業利潤是多少？



Vyne Therapeutics Inc 2025 財年的營業利潤為 -29.75M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。